Pulmonary Disease Doctors in Hot Springs, AR Accepting Medicare

7 Pulmonary Disease doctors found. Showing 1 - 7

Jessica Treat, APRN Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1900 Malvern Ave Ste 302, Hot Springs, AR 71901 Phone: 501-624-4700    Fax: 501-624-4705

Dr. Janice J Gunnels, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 238 Marsh Harbor Dr, Hot Springs, AR 71913 Phone: 501-262-0551    Fax: 501-262-9883

Nayneshkumar Patel, Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1900 Malvern Ave Ste 302, Hot Springs, AR 71901 Phone: 501-624-4700

Dr. Syed Mustafa, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Mercy Ln Ste 401, Hot Springs, AR 71913 Phone: 501-623-5220    Fax: 501-623-1546

Dr. Jovan Andre Gayle, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1 Mercy Ln Ste 401, Hot Springs, AR 71913 Phone: 501-623-5220    Fax: 501-623-1546

Albert J Chinn, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1900 Malvern Ave, Suite 301, Hot Springs, AR 71901 Phone: 501-624-4700    Fax: 501-624-4705

Dr. Robert D Johnson, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Mercy Ln, Ste 401, Hot Springs, AR 71913 Phone: 501-623-5220    Fax: 501-623-1546

News Archive

Drug used for breast, renal cancers may provide survival benefit for patients with head and neck cancers

A targeted therapy drug used for breast and kidney cancers may also extend progression-free survival for patients with advanced head and neck cancer who are at high risk for recurrence after standard treatment.

Eating fish protects from blindness: Study

According to latest study fish that is rich in omega 3 fatty acids significantly lowers the risk of developing age-related macular degeneration that leads to blindness. The study was published in the Archives of Ophthalmology.

Noven completes LDMP Phase 3 studies on menopausal VMS

Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms (VMS) associated with menopause.

HHS awards $15M to create new center for health information and privacy at University of Illinois

Slowly but steadily the U.S. health care community is moving into the digital age: shifting their medical records from paper to electronic information systems. This movement raises serious concerns about security and privacy of patients' medical information. In an attempt to put these concerns to rest, the U.S. Department of Health and Human Services has awarded $15 million to create a new center for health information and privacy.

Read more Medical News

› Verified 8 days ago